home / stock / clvs / clvs news


CLVS News and Press, Clovis Oncology Inc. From 06/23/22

Stock Information

Company Name: Clovis Oncology Inc.
Stock Symbol: CLVS
Market: NASDAQ
Website: clovisoncology.com

Menu

CLVS CLVS Quote CLVS Short CLVS News CLVS Articles CLVS Message Board
Get CLVS Alerts

News, Short Squeeze, Breakout and More Instantly...

CLVS - Zai Lab, Xenon Pharmaceuticals among premarket losers' pack

Applied Therapeutics ( APLT ) -22% on pricing $30M equity offering . Xenon Pharmaceuticals ( XENE ) -13% on pricing $250M equity offering . Clovis Oncology ( CLVS ) -10% Zai Lab ( ZLAB ) -9% on conversion of secondary listing in Ho...

CLVS - CLVS Stock Alert: 7 Things to Know as Clovis Oncology Soars 70%

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the most impressive movers in today’s green market is Clovis Oncology  (NASDAQ: CLVS ). Today, CLVS stock is up approximately 50% in this afternoon session on continued excitement around previously-...

CLVS - Best Penny Stocks to Buy This Week? 3 to Watch as June Ends 

3 Penny Stocks to Add to Your End of June Watchlist Finding penny stocks that are worth buying right now can be challenging. With so much volatility in the stock market, investors need to have a thorough understanding of exactly what is going on. This is the best and only way that trade...

CLVS - SRNE, ODP and MGNX among mid-day movers

Gainers: Convey Health Solutions Holdings (CNVY) +139%. Valneva (VALN) +86%. Green Giant (GGE) +78%. CEA Industries (CEAD) +76%. Clovis Oncology (CLVS) +71%. Tabula Rasa HealthCare (TRHC) +34%. Revlon (REV) +34%. Innate Pharma (IPHA) +33%. Sorrento Therapeutics (SRNE) +28%. MacroGenics (MGNX)...

CLVS - Why Clovis Oncology Stock Is Blasting Off Today

Shares of Clovis Oncology (NASDAQ: CLVS) headed for the moon on Tuesday after the company reported positive interim phase 1/2 clinical trial results for one of its therapies on June 14, with its shares up by more than 65% as of 11 a.m. ET today before pulling back slightly. Of t...

CLVS - Convey, Valneva top healthcare gainers; ACADIA, Comera Life lead losers' pack

Gainers: Convey Health Solutions CNVY +139%. Valneva  VALN +87%. Clovis Oncology (CLVS) +34%. Innate Pharma (IPHA) +28%. Lexaria Bioscience (LEXX) +20%. Losers: ACADIA Pharmaceuticals ACAD -34%. Comera Life Sciences Holdings (CMRA) -17%. ...

CLVS - HSBC, CLVS and HUT among pre market gainers

Convey Health Solutions (CNVY) +138% on to be taken private by TPG. Valneva (VALN) +85% as Pfizer to buy 8.1% stake in Valneva. Innate Pharma (IPHA) +29%. BlackSky Technology (BKSY) +25% on being awarded up to $241M basic order agreement from JAIC. Symbotic (SYM) +17%. Clovis O...

CLVS - 3 Biotech Penny Stocks That Climbed in After-Hours Trading

Check These 3 Biotech Penny Stocks Out For Your Watchlist If you’re looking for biotech penny stocks to buy, there are hundreds of options to choose from. And while it may seem simple, it can be quite an arduous process to find biotech stocks that are worth investing in. Whil...

CLVS - Clovis Oncology (CLVS) Stock Gains 20% on Tumor Trials, Buyout Hopes

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock / PopTika This week has been a relatively dismal one for overall markets. However, investors in specific companies like Clovis Oncology  (NASDAQ: CLVS ) have seen impressive gains. CLVS st...

CLVS - Best Penny Stocks To Buy Now? 4 To Watch After June's Fed Meeting

The June Federal Reserve meeting has concluded, and the stock market has responded. Investors and traders alike have begun positioning themselves based on the latest commentary from Jerome Powell’s FOMC press conference. The interesting part about this is that some stocks don’...

Previous 10 Next 10